Please CLICK HERE for the AVID 2012 Program.

Please visit the Invited Speakers page for information on the speakers for 2012.

Day 1: Wednesday, May 2nd, 2012
8:00am Registration
9:00am - 10:30am Session One: Inaugural Session
Chairperson: Jose Villadangos
9:00am - 9:15am Welcome
9:15am - 10:00am Opening Plenary Lecture
Prof. Gustav Nossal (University of Melbourne)
Immunology and World Health   
10:00am - 10:30am Keynote Lecture
Prof. Bob Seder (Vaccine research Centre, NIH, USA)
Innate and Antigenic Requirements for Optimizing CD8+ T Cell Immunity with Viral Vaccines
10:30am - 11:00am Morning Tea
11:00am - 12:30pm Session Two: Emerging therapeutics for Autoimmunity
Chairperson: Christian Engwerda

11:00am - 11:20am Prof. Ranjeny Thomas (University of Queensland, Brisbane)
Clinical development and trials of antigen-specific dendritic cell tolerising immunotherapy for rheumatoid arthritis    
11:20am - 11:40am Prof. Len Harrison (WEHI, Melbourne, VIC)
Autoantigen-specific vaccination for prevention of type 1 diabetes: new evidence and insights
11:45am - 11:55am Susan Christo (Hanson Institute, SA)
Developing a functionalised platform for the measurement of early T cell responses   
11:55am - 12:05pm Rangsima Reantragoon (University of Melbourne, VIC)
MAIT Cells: Understanding their Interaction with MR1    
12:10pm - 12:30pm A/Prof  Lars M. Ittner (University of Sydney, NSW)
Targeting Tau for the Treatment of Alzheimer's Disease and Related Forms of Dementia
12:10pm - 1:00pm Lunch
1:30pm - 2:30pm Session Three: Designing vaccines to induce T cell responses
Chairperson: Simon Apte
1:30pm - 1:50pm Dr. Scott Mueller (University of Melbourne, VIC)
Dissecting the roles of protective anti-viral T cell responses in the skin    
1:55pm - 2:05pm Laura Mackay  (University of Melbourne, VIC) 
Efficient epithelial immunity by site-directed lodgement of tissue-resident memory T cells    
2:10pm - 2:30pm
Assoc. Prof. Scott Burrows (UACVD, QIMR, Brisbane)
Human leukocyte antigen peptide length preferences control antiviral CD8+ T cell responses    
2:30pm - 3:30pm Session Four: Therapeutic Vaccination in Cancer
Chairperson: Ranjeny Thomas
2:30pm - 2:50pm Dr. Kristen Redford (MMRI, Brisbane, Qld)
Targeting the cross-presenting dendritic cells for immunotherapy
2:55pm - 3:05pm Adriana Baz Morelli (CSL Ltd, VIC)
Therapeutic efficacy of an ISCOMATRIX® adjuvant vaccine in a mouse model of prostate cancer    
3:10pm - 3:30pm Dr. Jonathan Cebon (Ludwig Institute, Melbourne)
Targeting defined cancer antigens – lessons from NY-ESO-1    
3:30pm - 4:00pm Afternoon Tea
4:00pm - 5:30pm Session Five: Malaria vaccine - bench to bedside
Chairperson: Mireille Lahoud
4:00pm - 4:20pm Prof. Louis Schofield (WEHI, Melbourne, Vic)
Development of two novel pan-species, multi-stage vaccines for malaria    
4:25pm - 4:45pm Prof. Denise Doolan (ACVD, QIMR, Brisbane)
Rational design of T cell inducing vaccines against complex pathogens from genomic sequence data    
4:50pm - 5:00pm Alberto Pinzon (QIMR, QLD)
Apoptosis and Dysfunction of Blood Dendritic Cells in Patients with falciparum and vivax Malaria: Implications for vaccine development   
5:00pm - 5:10pm Jennifer Reiman (Griffith University, QLD)
Development of a High Throughput Screening Assay to Identify Novel Vaccine Adjuvants from Natural Products for Malaria Vaccines    
5:10pm - 5:30pm Prof. James McCarthy (ACVD, QIMR, Brisbane)
Using human experimental infection to characterise the early events in the immune response to malaria
5:30pm - 6:30pm Welcome Drinks and Poster Viewing

Day 2: Thursday, May 3rd, 2012
8:45am - 9:30am
Plenary Lecture - II
Prof. Graham Brown (University of Melbourne)
Malaria immunity and its importance for malaria control, elimination, and the development of vaccines
9:30am - 10:30am
Session Six: Immunotherapeutics in Transplantation
Chairperson: Gabrielle Belz
9:30am - 9:50am Assoc. Prof. Maher Gandhi (ACVD, QIMR, Brisbane)
Modulation of Rituximab-dependent ADCC: implications for Post-Transplant Lymphoproliferative Disorders
9:55am - 10:05am Mireille Lahoud (Burnet Institute, VIC)
The Dendritic Cell Receptor Clec9A: Damaged Cell Recognition and Immune Modulation    
10:10am - 10:30am Prof. Peter Cowan (University of Melbourne, VIC)
Prospects for Xenotransplantation    
10:30am - 11:00am Morning Tea
11:00am - 12:30pm Session Seven:  Cellular Therapy for Cancer and infectious Diseases  
Chairperson: Kristen Radford
11:00am - 11:30am Keynote Lecture
Prof. Helen Heslop (Baylor Medical College, Texas, USA)
Adoptive Immunotherapy Targeting Viral Antigens     
11:35am - 11:45am Simon Apte (QIMR, QLD)
Targeting vaccines to skin dendritic cells for optimal CD8+ T cell responses 
11:45am - 11:55am Gregory Woods (Menzies Research Institute Tasmania, TAS)
Can NK-like cells be exploited to protect against Devil Facial Tumour Disease?    
11:55am - 12:05pm Kaja Murali-Krishna (Emory University, USA)
Role of type-I interferons in T cell expansion and memory differentiation
12:10pm - 12:30pm Dr. Jose Villadangos (University of Melbourne, Vic)
Adoptive immunotherapy targeting blood cancer
12:30pm - 1:30pm Lunch
1:30pm - 3:00pm Session Eight: Challenges in designing multi-strain vaccine against influenza
Chairperson: Scott Mueller
1:30pm - 2:00pm Keynote Lecture
Prof. Rafi Ahmed (Emory Vaccine Centre, Atlanta, USA)
Human B cell Response to Influenza Virus   
Sponsored by the Australian Centre for Vaccine Development  
2:05pm - 2:15pm Melisa Rike Anggraeni (Australian Institute for Bioengineering and Nanotechnology, QLD)
Design of Influenza Antigen for Presentation on Virus-Like Particles (VLPs)    
2:15pm - 2:25pm Karen Laurie (WHO Collaborating Centre for Influenza, VIC)
Antigenic drift of the A(H1N1)pdm virus in the ferret model of vaccination
2:25pm - 2:35pm Natalie Stevens (Experimental Therapeutics Laboratory, SA)
Production and evaluation of ovine polyclonal antibodies for passive protection against viral infection  
2:40pm - 3:00pm Dr. Katherine Kedzierska (University of Melbourne, VIC)
Defining cross-strain protective T cell immunity across different HLAs: insights into a universal influenza vaccine
3:00pm - 3:30pm
Afternoon Tea
3:30pm - 5:30pm Session Nine: Developing therapeutic strategies for chronic diseases
Chairperson: Eric Gowans
3:30pm - 4:00pm Keynote Lecture
Prof. Ed Mocarski (Emory Vaccine Centre, USA)
Unmet Medical Need: Perspective on Herpesvirus Vaccines: The Strategy Forward
4:00pm - 4:10pm Cynthia Derdeyn (Emory University, USA)
Early Neutralizing Antibodies in HIV-1 Infection    
4:10pm - 4:20pm Julie Dutton (Coridon Pty Ltd, QLD)
Mixed polynucleotide vaccines protect against viral challenge in a murine model of HSV-2 infection
4:20pm - 4:30pm Michelle Wykes (Queensland Institute of Medical Research, Australia) 
Implication of rodent blood stage Plasmodium surviving in dendritic cells
4:30pm - 4:40pm Abdullah Ahmad Fuaad (University of Queensland, QLD)
Size Dependent Poly(t-butyl)acrylate (PtBA) - J14 Peptide Vaccine against Group A Streptococcus (GAS)    
4:40pm - 4:50pm Erin Lousberg (Adelaide University, SA)
MyD88 signalling within T cells is critical for adaptive T cell responses to recombinant fowlpox viral vaccines
4:50pm - 5:00pm Jian Hang Lam (National University of Singapore, Singapore)
Expression and delivery of dengue EDIII by Bordetella pertussis BPZE1 via the BrkA autotransporter     
5:00pm - 5:10pm Joshy Jacob (Emory University, USA)
Redemption from original antigenic sin
5:10pm - 6:45pm Poster Viewing 
7:00pm - 10:00pm Conference Dinner (Decks Restaurant, South Bank)
Michael Good -
The long road to a malaria vaccine

Day 3: Friday, May 4th, 2012
9:00am - 10:30am Session Ten: New innovations in vaccines and Immunotherapeutics
Chairperson: Adriana Bazmorelli
9:00am - 9:20am Prof. Tony Cunningham (Westmead Millennium Institute)
HIV subversion of Dendritic cell functions: Implications for vaccines and immunotherapy
9:20am - 9:40am Prof. Anton Middleberg (University of Queensland)   
A microbial platform for low-cost virus-like particle (VLP) vaccines
9:40am - 10:00am Prof. Deb Middleton (CSIRO, Melbourne, Vic)
Hendra virus countermeasures: the state of play
10:00am - 10:20am Prof. Istavan Toth (University of Queensland, Brisbane)
Delivery systems for peptide vaccines

10:30am - 11:00am Morning Tea
11:00am - 12:00pm
Session Eleven: Vaccine Market, Strategic Planning and Industry Trends
Chairperson:iAN bARR
11:00am - 11:20am Prof. Nikolai Petrovsky (AdVax, Adelaide, SA)
Vaccine Adjuvants; Past, Present and Future
11:20am - 11:40am Dr Robbert van der Most (GSK Biologicals, Belgium)    
11:40am - 12:00pm Dr. Jim Ackland (Global Biosolutions)
Early regulatory challenges in vaccines development - making the transition from the research bench to the clinic 
12:00pm - 12:15pm Closing announcements and best poster presentations


11:00am - 12:30pm